The Oncology Institute Blog
New Clinics & Acquisitions
TOI Continues Expansion in South Florida with Clinics in Miami-Dade County
The Oncology Institute Expands into Miami-Dade County; Hires National Oncology Leader Dr. Roberto Ochoa The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based ...
Read More →
5 Fast Facts
5 Fast Facts: Myths About Prostate Cancer
Prostate cancer affects men second most commonly after skin cancer. Take 5 minutes to read about the prostate and some common myths about prostate cancer. ...
Read More →
TOI in the News
Dr. John Schwerkoske Speaks to Fox 5 San Diego for Breast Cancer Awareness Month
October is Breast Cancer Awareness month. Dr. John Schwerkoske made an appearance on Fox 5 KSWB-TV to discuss the warning signs of breast cancer, as ...
Read More →
Press Release
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
TOI executive visibility is increasing this year as the company experiences growth in new markets driven by market demand and investor interest in its proven ...
Read More →
TOI in the News
Dr. Merrill Shum Speaks to Fox 11 News About the Correlation Between Wildfires and Lung Disease
A recent study found that people living within 30 miles of wildfires are 5% more likely to develop lung cancer and ...
Read More →
Leadership
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Research
Phil Reger and Cristina Green Will Serve as the Chief Information Officer and Vice President of Clinical Research, Respectively CERRITOS, Calif., Oct. 11, 2022 (GLOBE ...
Read More →
New Clinics & Acquisitions
The Oncology Institute Expands into South Florida
Two clinics and two physicians join TOI as it enters Broward County CERRITOS, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: ...
Read More →
Patient Stories
Shared Hope to Overcome Breast Cancer: Denise’s Story
October is Breast Cancer Awareness Month. Breast cancer is the second most prominent cancer among women in the US. TOI teammate and breast cancer survivor, ...
Read More →
Clinical Trials
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), today announces the ...
Read More →
Investor Relations
The Oncology Institute Appoints Two New Board Members
Expands board to 9 members with deep healthcare management and investment experience CERRITOS, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: ...
Read More →
